Tin tức & Cập nhật
Xem bài viết Đa khoa
Xem

Benralizumab provides cough, dyspnoea relief in severe asthma
In a post hoc analysis of the phase III MIRACLE trial, benralizumab relieves cough and/or dyspnoea and improves cough-specific health-related quality of life (HRQoL) in individuals with severe eosinophilic asthma (SEA).

Over 40 percent of patients with delusional disorder later transition to schizophrenia
Over 10 years, 41 percent of patients initially diagnosed with delusional disorder transitioned to schizophrenia, a 10-year prospective comparison study in Hong Kong has shown. The results also showed a lower burden of adverse clinical outcomes with stable delusional disorder compared with stable schizophrenia.

Parathyroidectomy reduces MACE risk in primary hyperparathyroidism
In patients with primary hyperparathyroidism (PHPT), parathyroidectomy significantly reduces the risk of major adverse cardiovascular events (MACE), a population-wide target trial emulation (TTE) study in Hong Kong has shown.





